Inexpensive malaria drugs are becoming useless due to widespread resistance in malaria parasites. A relatively new drug called Artemisinin, developed from an herbal medicine used in China for years, has proved effective in Asia, but its relatively high cost puts it out of reach for many people in areas where malaria is endemic. A new report by the Institute of Medicine at the National Academies recommends the broadest possible access to Artemisinin-based combination therapies around the world. NPR's Joanne Silberner reports.
Copyright 2022 NPR. To see more, visit https://www.npr.org.
